Results 181 to 190 of about 7,636 (247)
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Hemagglutinin precomplexation with antibodies (Abs) results in broad valency distributions, though it increases the total avidity from mM to nM to high nM. The valency distribution and the orientation of multivalent HA‐Ab complexes determine the extent of binding to different types of assays, whether the receptors are displayed in 2D or 3D.
Daniel Y. E. L. Tambuwun +8 more
wiley +1 more source
ABSTRACT Diabetic stroke is characterized by a hyperglycemic and pro‐inflammatory microenvironment that exacerbates neurovascular dysfunction. However, the blood–brain barrier (BBB) remains a formidable obstacle, restricting the delivery of most therapeutic molecules.
Bixin Shen +7 more
wiley +1 more source
MXene‐based potassium‐ion battery anodes are mapped by linking synthesis, surface chemistry, heterostructure design, and practical evaluation. Pristine MXenes and composites with carbon, oxides, sulfides, selenides, tellurides, and alloying phases are compared, while intercalation, pseudocapacitive, conversion/alloying, built‐in‐field, and trapping ...
Haohao Ding +6 more
wiley +1 more source
The main purpose of this review is to summarize recent progress in the broad family of carbon‐based materials and their derivatives for CO2 capture. Rather than focusing on a single precursor or modification route, it examines pristine carbon adsorbents, functionalized carbon derivatives, and carbon‐based composites within a unified framework.
Jinliang Cai +4 more
wiley +1 more source
Abstract Objectives Viral infections are predominantly managed with conventional antiviral drugs, which, despite their efficacy, can cause toxicity and promote resistance. Cell‐based immunotherapies offer an alternative, but cytomegaloviruses (CMV) profoundly interfere with MHC class I antigen presentation, thereby impairing conventional virus‐specific
Sabrina Kübel +14 more
wiley +1 more source
Air Stability of Sulfide Solid Electrolytes: From Theoretical Insights to Practical Solutions
This paper reviews research progress on the air stability of SSEs, covering their instability mechanisms and modification strategies, while outlining core challenges and future directions for practical applications. Sulfide solid electrolytes are pivotal for enabling high‐performance all‐solid‐state batteries due to their high ionic conductivity and ...
Hongbing Ding +10 more
wiley +1 more source
Primary lymphatic endothelial cells, lymphatic muscle cells, and human dermal fibroblasts self‐assemble into spheroids within defined, tunable PEG‐4MAL hydrogels, creating a bottom‐up sprouting assay. Rat collecting‐vessel spheroid sprouting peaks at intermediate stiffness (8% and 10% PEG‐4MAL), is rescued at low stiffness by VEGF‐C, and is suppressed ...
Yarelis Gonzalez‐Vargas +7 more
wiley +1 more source
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang +15 more
wiley +1 more source
Targeted Protein Degradation: From Molecular Mechanisms to Emerging Therapeutic Strategies
Graphical overview of targeted protein degradation: mechanisms, molecular determinants, delivery strategies, and therapeutic development. This graphical abstract summarizes the major degradation pathways involved in targeted protein degradation, including the ubiquitin–proteasome system, endocytosis–lysosome pathway, and autophagy‐dependent degradation.
Huaijuan Guo +8 more
wiley +1 more source

